Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Hong Kong Med J ; 29(6): 532-541, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37385947

ABSTRACT

Helicobacter pylori infection causes chronic gastric inflammation that contributes to various gastroduodenal diseases, including peptic ulcer and gastric cancer. Despite broad regional variations, the prevalence of resistance to antibiotics used to manage H pylori infection is increasing worldwide; this trend could hinder the success of eradication therapy. To increase awareness of H pylori and improve the diagnosis and treatment of its infection in Hong Kong, our consensus panel proposed a set of guidance statements for disease management. We conducted a comprehensive review of literature published during 2011 and 2021, with a focus on articles from Hong Kong or other regions of China. We evaluated the evidence using the Oxford Centre for Evidence-Based Medicine's 2011 Levels of Evidence and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system and sought consensus through online voting and a subsequent face-to-face meeting, which enabled us to develop and refine the guidance statements. This report consists of 24 statements regarding the epidemiology and burden, screening and diagnosis, and treatment of H pylori. Key guidance statements include a recommendation to use the test-and-treat approach for high-risk individuals, as well as the confirmation that triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin remains a valid first-line option for adults and children in Hong Kong.


Subject(s)
Helicobacter Infections , Helicobacter pylori , Adult , Child , Humans , Helicobacter Infections/diagnosis , Helicobacter Infections/drug therapy , Helicobacter Infections/epidemiology , Hong Kong/epidemiology , Consensus , Anti-Bacterial Agents/therapeutic use
2.
Hong Kong Med J ; 26(5): 390-396, 2020 10.
Article in English | MEDLINE | ID: mdl-32908008

ABSTRACT

INTRODUCTION: There is a global trend of increasing macrolide and fluoroquinolone resistance in Mycoplasma genitalium (MG), such that international guidelines recommend molecular detection of resistance if a patient has MG-positive test results. Tests for MG are not routinely performed in Hong Kong. This study examined the detection of MG in endocervical swabs and the associated macrolide and fluoroquinolone resistance rates. METHODS: Endocervical swabs received from two sexual health clinics in Hong Kong for routine assessments of Chlamydia trachomatis and Neisseria gonorrhoeae were also subjected to detection of MG. All MG-positive samples were tested for resistance-mediating mutations in 23S rRNA, parC, and gyrA genes. Laboratory records and past results for each patient were analysed. RESULTS: In total, endocervical swabs from 285 patients were included in this study. Mycoplasma genitalium was detected in swabs from 21 patients (7.4%) by real-time polymerase chain reaction with a commercial kit. Among MG-positive samples which were successfully analysed further, macrolide resistance-mediating mutations in 23S rRNA were found in 42.1% (8/19); fluoroquinolone resistance-related mutations in parC and gyrA were found in 65% (13/20) and 0% (0/20), respectively. All macrolide-resistant MG strains were also fluoroquinolone-resistant (42.1%, 8/19). No assessed factors were associated with the detection of MG or resistance-related mutations. CONCLUSION: In Hong Kong, MG was detected in endocervical swabs from 7.4% of patients in sexual health clinics, with high rates of macrolide and fluoroquinolone resistance. These findings warrant careful review of testing, clinical correlation, and treatment strategies for MG in the context of increasing antibiotic resistance.


Subject(s)
Drug Resistance, Bacterial/genetics , Fluoroquinolones , Macrolides , Molecular Typing/methods , Mycoplasma genitalium/drug effects , Adolescent , Adult , Aged , Cervix Uteri/microbiology , Female , Hong Kong/epidemiology , Humans , Middle Aged , Mycoplasma Infections/diagnosis , Mycoplasma Infections/epidemiology , Mycoplasma Infections/microbiology , Mycoplasma genitalium/genetics , RNA, Bacterial/analysis , Uterine Cervical Diseases/diagnosis , Uterine Cervical Diseases/epidemiology , Uterine Cervical Diseases/microbiology , Young Adult
4.
Hong Kong Med J ; 24(2): 119-127, 2018 04.
Article in English | MEDLINE | ID: mdl-29633715

ABSTRACT

INTRODUCTION: Under the current opt-in system, the deceased organ donation rate remains low in Hong Kong. An opt-out system and an opt-in system combined with organ allocation priority (ie, priority to donors as transplant recipients) have been proposed to encourage willingness among the general population towards deceased organ donation. This study aimed to compare willingness, and its determinants, across these three legislative systems. METHODS: A random telephone survey of Hong Kong permanent residents aged ≥18 years was conducted between August and October 2016 using an anonymous questionnaire. Willingness towards deceased organ donation was compared between the legislative systems with McNemar's test. Determinants of willingness were tested by logistic regression. RESULTS: The proportion of those willing to consider deceased organ donation under the current opt-in system would significantly increase after combining it with allocation priority (64.5% vs 73.4%; P=0.018). "Fairness or reciprocity" was the major reported reason underlying the increase. In contrast, willingness would decrease after introducing the opt-out system (60.1%), although not significantly (P=0.336). The reduction might be attributable to a "belief of being forced to donate". Under the allocation priority system, reduced willingness to donate was associated with advanced age, lower educational attainment, and lower monthly household income. Under the opt-out system, reduced willingness was associated with being married, having a lower household income, and distrust of local government. CONCLUSIONS: An opt-in system with allocation priority could induce willingness to donate, whereas an opt-out system may reduce willingness. The findings have implications for policy-making and promotion of organ donation.


Subject(s)
Tissue and Organ Procurement/legislation & jurisprudence , Adolescent , Adult , Cross-Sectional Studies , Female , Hong Kong , Humans , Male , Policy Making , Young Adult
5.
Hong Kong Med J ; 23(6): 641-7, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29226832

ABSTRACT

OBJECTIVE: The estimated prevalence of irritable bowel syndrome in Hong Kong is 6.6%. With the increasing availability of pharmacological and non-pharmacological treatments, the Hong Kong Advisory Council on Irritable Bowel Syndrome has developed a set of consensus statements intended to serve as local recommendations for clinicians about diagnosis and management of irritable bowel syndrome. PARTICIPANTS: A multidisciplinary group of clinicians constituting the Hong Kong Advisory Council on Irritable Bowel Syndrome-seven gastroenterologists, one clinical psychologist, one psychiatrist, and one nutritionist-convened on 20 April 2017 in Hong Kong. EVIDENCE: Published primary research articles, meta-analyses, and guidelines and consensus statements issued by different regional and international societies on the diagnosis and management of irritable bowel syndrome were reviewed. CONSENSUS PROCESS: An outline of consensus statements was drafted prior to the meeting. All consensus statements were finalised by the participants during the meeting, with 100% consensus. CONCLUSIONS: Twenty-four consensus statements were generated at the meeting. The statements were divided into four parts covering: (1) patient assessment; (2) patient's psychological distress; (3) dietary and alternative approaches to managing irritable bowel syndrome; and (4) evidence to support pharmacological management of irritable bowel syndrome. It is recommended that primary care physicians assume the role of principal care provider for patients with irritable bowel syndrome. The current statements are intended to guide primary care physicians in diagnosing and managing patients with irritable bowel syndrome in Hong Kong.


Subject(s)
Irritable Bowel Syndrome/therapy , Adult , Hong Kong/epidemiology , Humans , Irritable Bowel Syndrome/epidemiology , Irritable Bowel Syndrome/prevention & control , Prevalence
6.
J Viral Hepat ; 21(11): 818-23, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24325347

ABSTRACT

In view of a persistently high prevalence of hepatitis B surface antigen (HBsAg) carriage in our obstetric population, we examined the association between HBsAg carriage with maternal ABO and rhesus (Rh) blood group phenotypes determined at routine antenatal screening. In a retrospective study, the antenatal screening results of women booked for confinement between 1998 and 2011 in our hospital were examined for the relationship between HBsAg carriage with the ABO and rhesus blood groups, taking into account also the effects of advanced maternal age (≥ 35 years) and parity status (nulliparous or multiparous), and year of birth before or following the availability of the hepatitis B vaccine (1984). HBsAg carriage was found in 9.9%, 9.6%, 9.1% and 10.2% (P = 0.037) for group-A (n = 20 581 or 26.1%), -B (n = 20 744 or 26.4%), -AB (n = 5138 or 6.5%) and -O (n = 32 242 or 41.0%) among the 78705 women in the study cohort. Rhesus negativity was found in 0.6%, and HBsAg carriage was 12.3% and 9.8%, respectively, for the Rh-negative and Rh-positive women (P = 0.071). Carriage rate between group-O and non-O was influenced by nulliparity, age ≥ 35 years and Rh-positive status. Regression analysis indicated that group-B (P = 0.044, aOR = 1.062, 95% CI 1.002-1.127) and group-AB (P = 0.016, aOR = 1.134, 95% CI 1.024-1.256) were associated with HBsAg carriage. Blood groups-B and -AB are associated with increased hepatitis B virus (HBV) infection in our population, and further studies are warranted to elucidate the implications of this on the sequelae of HBV infection.


Subject(s)
ABO Blood-Group System , Hepatitis B Surface Antigens/blood , Hepatitis B/epidemiology , Rh-Hr Blood-Group System , Adult , Cohort Studies , Female , Humans , Pregnancy , Retrospective Studies , Seroepidemiologic Studies
7.
Neuroscience ; 168(3): 613-23, 2010 Jul 14.
Article in English | MEDLINE | ID: mdl-20398740

ABSTRACT

It has previously been reported that the avian H5N1 type of influenza A virus can be detected in neurons and astrocytes of human brains in autopsy cases. However, the underlying neuropathogenicity remains unexplored. In this study, we used differentiated human astrocytic and neuronal cell lines as models to examine the effect of H5N1 influenza A viral infection on the viral growth kinetics and immune responses of the infected cells. We found that the influenza virus receptors, sialic acid-alpha2,3-galactose and sialic acid-alpha2,6-galactose, were expressed on differentiated human astrocytic and neuronal cells. Both types of cells could be infected with H5N1 influenza A viruses, but progeny viruses were only produced from infected astrocytic cells but not neuronal cells. Moreover, increased expression of interleukin (IL)-6 and/or tumor necrosis factor alpha (TNF-alpha) mRNA was detected in both astrocytic and neuronal cells at 6 and 24 h post-infection. To examine the biological consequences of such enhanced cytokine expression, differentiated astrocytic and neuronal cells were directly treated with these two cytokines. TNF-alpha treatment induced apoptosis, as well as proinflammatory cytokine, chemokine and inflammatory responses in differentiated astrocytic and neuronal cells. Taken together, our findings reveal that avian influenza H5N1 viruses can infect human astrocytic and neuronal cells, resulting in the induction of direct cellular damage and proinflammatory cytokine cascades. Our observations suggest that avian influenza H5N1 infection can trigger profound CNS injury, which may play an important role in the influenza viral pathogenesis.


Subject(s)
Astrocytes/virology , Cytokines/metabolism , Influenza A Virus, H5N1 Subtype/physiology , Neurons/virology , Apoptosis , Astrocytes/cytology , Astrocytes/immunology , Cell Differentiation , Cell Line , Chemokine CCL2/biosynthesis , Cyclooxygenase 2/biosynthesis , Cytopathogenic Effect, Viral , Galactose/analogs & derivatives , Galactose/biosynthesis , Humans , Influenza A Virus, H1N1 Subtype/physiology , Interleukin-6/biosynthesis , Interleukin-6/genetics , Neurons/cytology , Neurons/immunology , RNA, Messenger/biosynthesis , Receptors, Virus/biosynthesis , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/genetics
8.
Cancer Epidemiol Biomarkers Prev ; 16(12): 2637-40, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18086768

ABSTRACT

BACKGROUND: The incidence of esophageal adenocarcinoma was increasing in the Western Europe and United States, but not in East Asian countries. Population based study on the trend of esophageal adenocarcinoma in Hong Kong was not available. MATERIALS AND METHODS: Population-based data of Hong Kong Cancer Registry from 1984 to 2003 were used. Cases were grouped into four 5-year periods. Average age standardized rate (WSR) of each period was calculated by averaging the WSR of the 5 years in each period, basing on the world standard population, with adjustment made for cases with missing histology. RESULTS: 10,751 new cases of esophageal neoplasm were studied (8,637 males and 2,114 females). Esophageal adenocarcinoma declined among both males and females, with the total number decreased from 224 in 1984 to 1988 to 131 in 1998 to 2003. WSR decreased from 1.10 of 100,000 in 1984 to 1988 to 0.34 of 100,000 in 1998 to 2003. The decline was faster than that for esophageal squamous cell carcinoma so that the relative ratio of esophageal adenocarcinoma decreased from 11.7% in 1984 to 1988 to 6.4% in 1998 to 2003. CONCLUSIONS: The incidence of esophageal adenocarcinoma and ratio of esophageal adenocarcinoma versus esophageal squamous cell carcinoma decreased in Hong Kong.


Subject(s)
Adenocarcinoma/epidemiology , Esophageal Neoplasms/epidemiology , Carcinoma, Squamous Cell/epidemiology , Female , Hong Kong/epidemiology , Humans , Incidence , Male , Sex Distribution
9.
Aliment Pharmacol Ther ; 26(7): 1063-7, 2007 Oct 01.
Article in English | MEDLINE | ID: mdl-17877513

ABSTRACT

BACKGROUND: The efficacy of levofloxacin-based quadruple therapy in resistant Helicobacter pylori infection is not known. AIM: To test the efficacy of levofloxacin-based quadruple therapy and traditional quadruple therapy in resistant H. pylori infection. METHODS: One hundred and two patients with resistant H. pylori infection were randomized to 1 week of either EBAL (esomeprazole 40 mg b.d., bismuth subcitrate 240 mg b.d., amoxicillin 1 g b.d. and levofloxacin 500 mg b.d.) or EBMT (esomeprazole 40 mg b.d., bismuth subcitrate 240 mg b.d., metronidazole 400 mg t.d.s. and tetracycline 500 mg q.d.s.). (13)C-urea breath test was performed at week 12 to assess post-treatment H. pylori status. RESULTS: In intention-to-treat analysis H. pylori eradication was achieved in 37 of 51 (73%) subjects in EBAL and 45 of 51 (88%) subjects in EBMT groups, respectively (P = 0.046). Per-protocol eradication rates of EBAL and EMBT groups were 78% and 94%, respectively (P = 0.030). The intention-to-treat eradication rate was statistically lower for EBAL than EMBT (56% vs. 90%, P = 0.013) among those who had failed more than one course of eradication therapy. Previous levofloxacin triple therapy did not affect the efficacy of either protocol significantly. CONCLUSIONS: Levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy for resistant H. pylori infection.


Subject(s)
Amoxicillin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Esomeprazole/therapeutic use , Helicobacter Infections/drug therapy , Helicobacter pylori , Levofloxacin , Ofloxacin/therapeutic use , Adult , Aged , Amoxicillin/pharmacology , Anti-Bacterial Agents/pharmacology , Breath Tests , Drug Therapy, Combination , Esomeprazole/pharmacology , Female , Helicobacter Infections/metabolism , Humans , Male , Middle Aged , Ofloxacin/pharmacology , Treatment Outcome
10.
Aliment Pharmacol Ther ; 26(4): 597-603, 2007 Aug 15.
Article in English | MEDLINE | ID: mdl-17661763

ABSTRACT

BACKGROUND: Non-cardiac chest pain is an important disorder in Asia. The practice and views of gastroenterologists on non-cardiac chest pain in this region are not known. AIMS: To determine the current understanding, diagnostic practice and treatment strategies among gastroenterologists on the management of non-cardiac chest pain in Asia. METHODS: A 24-item questionnaire was sent to gastroenterologists in Mainland China, Hong Kong, Malaysia, Indonesia, Philippines, Singapore, Taiwan and Thailand. RESULTS: 186 gastroenterologists participated with a response rate of 74%. 98% of gastroenterologists managed patients with non-cardiac chest pain over the last 6 months. 64% felt that the number of non-cardiac chest pain patients was increasing and 85% believed that the most common cause of non-cardiac chest pain was GERD. 94% of the gastroenterologists believed that they should manage non-cardiac chest pain patients, but only 41% were comfortable in diagnosing non-cardiac chest pain. The average number of investigations performed was four in non-cardiac chest pain patients, and oesophago-gastro-duodenoscopy was the most commonly used initial test. A proton pump inhibitor was considered the first-line treatment in non-cardiac chest pain and was reported as the most effective treatment by the gastroenterologists. CONCLUSION: Most gastroenterologists were practicing evidence-based medicine, but frequent use of investigations and a lack of awareness of the role of visceral hypersensitivity in non-cardiac chest pain patients were noted.


Subject(s)
Anti-Ulcer Agents/therapeutic use , Chest Pain/therapy , Gastroenterology , Health Knowledge, Attitudes, Practice , Proton Pumps/therapeutic use , Adult , Asia , Chest Pain/etiology , Female , Gastroesophageal Reflux/diagnosis , Gastroesophageal Reflux/drug therapy , Health Services Accessibility , Humans , Male , Middle Aged , Patient Satisfaction , Primary Health Care , Surveys and Questionnaires
11.
Aliment Pharmacol Ther ; 25(9): 1099-104, 2007 May 01.
Article in English | MEDLINE | ID: mdl-17439511

ABSTRACT

BACKGROUND: Gastro-oesophageal reflux disease and irritable bowel syndrome are common diseases which may be related. AIM: To examine the association between gastro-oesophageal reflux disease and irritable bowel syndrome in Chinese population in Hong Kong. METHODS: Randomly selected ethnic Chinese were invited to participate in a telephone survey in 1996. Gastro-oesophageal reflux disease was defined as subjects having heartburn and/or acid regurgitation once weekly or more. Irritable bowel syndrome was diagnosed according to the Rome I criteria. The association between gastro-oesophageal reflux disease and irritable bowel syndrome was calculated using a statistical model which allows the odds ratio to be measured. RESULTS: One thousand six hundred and forty-nine subjects completed the interview (response rate 62%). The population prevalence of gastro-oesophageal reflux disease and irritable bowel syndrome were 5% and 4%, respectively. Thirteen per cent of subjects with gastro-oesophageal reflux disease and 11% with irritable bowel syndrome suffered from both gastro-oesophageal reflux disease and irritable bowel syndrome. The OR of having gastro-oesophageal reflux disease and irritable bowel syndrome together was estimated to be 3 (95% CI: 1.05, 6.27) indicating a positive association between the two diseases. This association occurred predominantly in male subjects [OR = 9.3, (95% CI: 2.3, 26.2)] but not as strong in females [OR = 1.5, (95% CI: 0.3, 4.3)]. Younger subjects were statistically more prone to the two diseases. CONCLUSIONS: There is a positive association between gastro-oesophageal reflux disease and irritable bowel syndrome, and their association occurs predominantly in male subjects.


Subject(s)
Gastroesophageal Reflux/etiology , Irritable Bowel Syndrome/etiology , Adolescent , Adult , Age Factors , Aged , Anxiety/complications , China/ethnology , Depressive Disorder/complications , Female , Gastroesophageal Reflux/ethnology , Hong Kong/epidemiology , Humans , Irritable Bowel Syndrome/ethnology , Male , Middle Aged , Prevalence , Sex Factors , Sick Leave/statistics & numerical data , Surveys and Questionnaires
13.
Aliment Pharmacol Ther ; 24(4): 573-83, 2006 Aug 15.
Article in English | MEDLINE | ID: mdl-16907890

ABSTRACT

BACKGROUND: Clinical features of hepatocellular carcinoma patients are changing because of screening. AIM: To examine the clinical features of hepatocellular carcinoma patients in Hong Kong and validity of different staging systems. METHODS: A total of 223 Chinese patients with hepatocellular carcinoma were studied. RESULTS: Seventy-eight percent of hepatocellular carcinoma patients had chronic hepatitis B (43% diagnosed by screening). Hepatitis B positivity, weight loss, jaundice, encephalopathy, alpha-fetoprotein level, portal vein thrombosis, extrahepatic metastasis, and treatment were shown to be independent factors affecting survival. Of chronic hepatitis B patients, hepatitis B virus DNA levels (P = 0.001) and portal vein thrombosis (P = 0.008) were independent factors affecting survival. Seventy-six percent of chronic hepatitis B patients with hepatocellular carcinoma were hepatitis B e antigen negative. Screening patients had hepatocellular carcinoma detected at an earlier stage and better survival (median survival: 21 vs. 4 months, P < 0.0001). All staging systems had good stratification of survival. Prognosis and median survival generated were different when compared with the US data. CONCLUSIONS: Chronic hepatitis B was the most common cause of hepatocellular carcinoma in Hong Kong. High-risk chronic hepatitis B patients should be followed irrespective of the hepatitis B e antigen status. Hepatitis B virus DNA levels at the time of diagnosis are an important survival predictor. Screening detected hepatocellular carcinoma at an earlier stage and prolonged survival. Staging systems should be validated in different populations.


Subject(s)
Carcinoma, Hepatocellular/pathology , Hepatitis B, Chronic/etiology , Adult , Aged , Aged, 80 and over , Carcinoma, Hepatocellular/ethnology , Carcinoma, Hepatocellular/virology , China/ethnology , Female , Hong Kong/epidemiology , Humans , Male , Middle Aged , Survival Analysis
14.
Hum Reprod ; 20(12): 3532-8, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16123094

ABSTRACT

BACKGROUND: Divalent metal transporter 1 (DMT1) is a transmembrane glycoprotein which mediates the proton-coupled transport of a variety of divalent metal ions. Two isoforms, which differ by the presence (DMT1-IRE) or absence (DMT1-nonIRE) of an iron-responsive element (IRE) in their 3' untranslated region, are implicated in apical iron transport and endosomal iron transport respectively. Although the expression pattern of DMT1 isoforms is tissue specific in adult, data regarding its expression in embryonic tissues are lacking. METHODS: Semiquantitative RT-PCR and immunohistochemistry were used to study the mRNA and protein expression of both DMT1 isoforms in embryonic tissues between 8 and 14 weeks gestational age. RESULTS: DMT1-IRE and DMT1-nonIRE expressions were ubiquitous in embryonic tissues examined. In the lung, statistically significant correlations were found between the levels of DMT1 isoform expression and gestational age. In the placenta, DMT1-IRE was the predominantly expressed isoform. Both isoform proteins were localized in embryonic epithelial cellular membrane. CONCLUSION: Both DMT1 isoforms are ubiquitously expressed in embryonic tissues in the first trimester. Predominant DMT1-IRE isoform expression in placenta suggests an iron-regulatory mechanism reminiscent of that in the adult duodenum. Epithelial distributions of both DMT1 isoforms are associated with the absorptive or excretory functions of the expressed tissues.


Subject(s)
Cation Transport Proteins/biosynthesis , Cation Transport Proteins/chemistry , Gene Expression Regulation, Developmental , Gene Expression Regulation , Iron-Binding Proteins/biosynthesis , Iron-Binding Proteins/chemistry , Placenta/embryology , Adult , Biological Transport , DNA Primers/chemistry , Female , Gestational Age , Humans , Immunohistochemistry , Intestinal Mucosa/metabolism , Ions , Kidney/metabolism , Lung/metabolism , Placenta/metabolism , Pregnancy , Pregnancy Trimester, First , Protein Isoforms , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , Tissue Distribution
15.
J Gen Virol ; 86(Pt 5): 1447-1454, 2005 May.
Article in English | MEDLINE | ID: mdl-15831957

ABSTRACT

The aim of this study was to inhibit influenza virus M2 protein expression by mutating the splicing signal of the M gene. Mutations were introduced into the GU dinucleotide sequence at the 5'-proximal splicing site of the M gene (corresponding to nt 52-53 of M cRNA). Transfected cells expressing mutated M viral ribonucleoproteins failed to generate M2 mRNA. Interestingly, recombinant viruses with mutations at the dinucleotide sequence were viable, albeit attenuated, in cell culture. These recombinants failed to express M2 mRNA and M2 protein. These observations demonstrated that the GU invariant dinucleotide sequence at the 5'-proximal splicing site of M gene is essential for M2 mRNA synthesis. These results also indicated that the M2 ion-channel protein is critical, but not essential, for virus replication in cell culture. This approach may provide a new way of producing attenuated influenza A virus.


Subject(s)
Influenza A virus/chemistry , Influenza A virus/genetics , Introns , Point Mutation , Viral Matrix Proteins/biosynthesis , Viral Matrix Proteins/genetics , Cells, Cultured , Humans , Influenza A virus/growth & development , RNA, Messenger/analysis , RNA, Messenger/biosynthesis , RNA, Viral/analysis , RNA, Viral/biosynthesis
17.
Emerg Infect Dis ; 7(5): 906-8, 2001.
Article in English | MEDLINE | ID: mdl-11747711

ABSTRACT

Serotypes 6A/B, 19F, and 23F accounted for 73% of 140 mucosal isolates of Streptococcus pneumoniae from Hong Kong. In pulsed-field gel electrophoresis analysis, a group of related patterns was shared by 14 of 15 ciprofloxacin-resistant and 12 of 16 ciprofloxacin-susceptible isolates. These strains exhibited capsular switching and were highly similar to the Spanish 23F clone.


Subject(s)
Anti-Infective Agents/pharmacology , Ciprofloxacin/pharmacology , Drug Resistance, Multiple, Bacterial , Pneumonia, Pneumococcal/epidemiology , Pneumonia, Pneumococcal/microbiology , Streptococcus pneumoniae/drug effects , Adolescent , Adult , Anti-Bacterial Agents/pharmacology , Child, Preschool , Electrophoresis, Gel, Pulsed-Field , Erythromycin/pharmacology , Hong Kong/epidemiology , Humans , Infant , Microbial Sensitivity Tests , Middle Aged , Penicillins/pharmacology , Serotyping , Spain/epidemiology , Streptococcus pneumoniae/classification , Streptococcus pneumoniae/genetics
18.
J Electromyogr Kinesiol ; 11(2): 95-112, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11228423

ABSTRACT

A three-dimensional, six-segment model was applied to the pitching motion of three professional pitchers to analyze the kinematics and kinetics of the hips, upper trunk, humerus and forearm plus hand of both the upper limbs. Subjects were filmed at 250 frames per second. An inverse dynamics approach and angular momentum principle with respect to the proximal endpoint of a rigid segment were employed in the analysis. Results showed considerable similarities between subjects in the kinetic control of trunk rotation about the spine's longitudinal axis, but variability in the control of trunk lean both to the side and forward. The kinetics of the throwing shoulder and elbow joint were comparable between subjects, but the contribution of the non-throwing upper limb was minimal and variable. The upper trunk rotators played a key role in accelerating the ball to an early, low velocity near stride foot contact. After a brief pause they resumed acting strongly in a positive direction, though not enough to prevent trunk angular velocity slowing, as the musculature of the arm applied a load at the throwing shoulder. The interaction moment from the proximal segments assisted the forearm extensor in slowing flexion and producing rapid elbow extension near ball release. The temporal onset of muscular torques was not in a strictly successive proximal-to-distal sequence.


Subject(s)
Arm/physiology , Baseball/physiology , Movement/physiology , Biomechanical Phenomena , Computer Simulation , Humans , Image Processing, Computer-Assisted , Male
19.
Fertil Steril ; 74(2): 299-305, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10927048

ABSTRACT

OBJECTIVE: To compare the potency, side effects, and duration of action of triptorelin and leuprorelin acetate after i.m. injections. DESIGN: Prospective, double-blind crossover clinical study. SETTING: A teaching hospital. PATIENT(S): Fifty-four patients with pelvic endometriosis. INTERVENTION(S): Twenty-seven patients had three doses of i.m. triptorelin (3.75 mg) followed by three doses of i.m. leuprorelin acetate at 4-week intervals. Twenty-one patients had three doses of i.m. leuprorelin acetate (3.75 mg) followed by three doses of i.m. triptorelin, also at 4-week intervals. MAIN OUTCOME MEASURE(S): Menopausal symptoms, time taken for menstruation to return, serum E(2), FSH, LH levels, lipid profiles, and liver function tests. RESULT(S): The potencies of triptorelin and leuprorelin acetate in lowering the serum E(2), FSH, and LH levels were comparable. The severity of menopausal symptoms, changes in the lipid profile and liver function parameters were similar after triptorelin and leuprorelin acetate. The resurgence of ovarian activities and the spontaneous return of menstruation occurred significantly earlier after leuprorelin acetate than triptorelin. CONCLUSION(S): Both drugs are equally potent in down-regulating the pituitary-ovarian function, and their side effects are similar. Triptorelin has a longer duration of drug action and can be administered over a longer interval period.


Subject(s)
Endometriosis/drug therapy , Leuprolide/therapeutic use , Triptorelin Pamoate/therapeutic use , Adult , Double-Blind Method , Estradiol/blood , Female , Follicle Stimulating Hormone/blood , Humans , Leuprolide/adverse effects , Liver/drug effects , Liver/physiology , Luteinizing Hormone/blood , Menopause , Menstruation , Prospective Studies , Triptorelin Pamoate/adverse effects
20.
Equine Vet J ; 30(3): 251-5, 1998 May.
Article in English | MEDLINE | ID: mdl-9622327

ABSTRACT

Surface electrodes were used to record electromyographic (EMG) activity of the long digital extensor muscle on the right hindlimb of 8 Thoroughbred horses for 8 s at the walk and 8 s at the trot before (unfatigued) and after (fatigued) an exercise test. The exercise test was performed on a motorised treadmill set on a 10% grade. Each test started at a speed of 6 m/s which was increased by 1 m/s each minute until the horse fatigued as indicated by its inability to keep pace with the treadmill with minimal encouragement. Observations were made on the horses prior to conditioning (untrained state) and after 8 weeks of regular exercise (trained state). The mean root-mean-square (rms) values of EMG bursts collected in each experimental trial were determined for each horse and group means were derived from the mean of independent subjects. Statistical comparisons for differences in rmsEMG were related to gait, fatigue and training. Mean rmsEMG at the trot was consistently higher than at the walk (P<0.05). At the walk, mean fatigued rmsEMG tended to be higher than the mean unfatigued rmsEMG in the untrained state and was significantly higher in the trained state (P<0.05). At the trot, mean fatigued rmsEMG was higher (P<0.05) than mean unfatigued rmsEMG in both the untrained and trained states. Training did not have an effect on mean rmsEMG of unfatigued muscles at the walk or the trot (P>0.05). However, fatigued muscles experienced higher EMG activity in the trained state at the walk (P<0.05). A similar tendency was observed at the trot. Results of this study suggest that surface EMG measurement may be useful for evaluating fatigue in exercising horses.


Subject(s)
Hindlimb/physiology , Horses/physiology , Muscle Fatigue/physiology , Muscle, Skeletal/physiology , Physical Conditioning, Animal/physiology , Animals , Electromyography/veterinary , Female , Gait/physiology , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...